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We commend Dr Gardella and colleagues for expanding the clinical and genetic spectrum of sodium 
channelopathies.1 However, we would like to comment on the unusual phenomenology of the 
paroxysmal attacks, and its implication with regard their labelling as paroxysmal kinesigenic 
dyskinesia (PKD).  
By definition, primary paroxysmal dyskinesias are characterised by brief, self-limiting attacks of 
dyskinesia, with no change in consciousness during attacks and normal inter-ictal neurological status 
differentiating them from secondary forms.2-4  
Based on triggering factors and duration of attacks, three main phenotypes are recognised.  PKD, the 
most frequent form, features brief (seconds to minutes) attacks of dystonia or chorea precipitated by 
sudden movement, or acceleration of ongoing movement.2-5 Proline-rich transmembrane protein 2 
(PRRT2) gene mutations are the most common cause, although there is some clinicogenetic 
heterogeneity.4,5 
 
The five individuals reported as having PKD1 differ significantly with regard nature and precipitants of 
attacks, and the fact that one had altered level of consciousness.    
Three patients had generalised “shivering attacks” triggered by emotional stimuli, which is not a 
recognised manifestation of paroxysmal dyskinesias neither by phenomenology nor by trigger. The 
triggers in the two other patients with attacks of hemidystonia or choreoathetosis of the legs were 
prolonged stretching of the limbs and “voluntary movements”.1 We acknowledge that “sudden 
whole body activity, like standing-up, or initiation of walking” were also named as precipitants, but it 
appears that mostly, the “kinesigenic” element is lacking. Lastly, the index case thought to have 
classical PKD had impaired consciousness during all events with an overt ictal EEG correlate.   
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Thus, from a movement disorders specialists view these do not constitute classic PKD and we think 
the readership should be aware of this.  
The identification of other cases may help to further delineate the spectrum of paroxysmal attacks 
associated with the new SCN8A mutations, and if they should be indeed be ranked amongst the 
classic paroxysmal dyskinesias or maybe be considered as epileptic events.   
We did not detect any pathogenic variant in SCN8A screening by whole exome sequencing our cohort 
of well defined cases with paroxysmal dyskinesias (9 PKD, 5 paroxysmal non-kinesigenic dyskinesia, 3 
paroxysmal exercise induced dyskinesia) negative for mutations in PRRT2, myofibrillogenesis 
regulator 1 (MR-1), or glucose transporter 1 (SCL2A1), respectively.  
Furthermore, none of our 72 patients with paroxysmal dyskinesias due to PRRT2, MR-1, or SCL2A1 
gene mutations5 had shivering attacks and it is possible that this may be a clinical feature particular 
to SCN8A mutations. 
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